The Government’s chief scientific advisor has requested that restrictions on the use of drug based cognitive performance enhancement be reviewed. The drugs in question were first developed for their disease treatment properties but are now found to enhance cognitive performance in the healthy.
Evidence from:
Sunday Times 4th June (2006)
“No 10 scientist urges brain pills for all”
The emergence of performance enhancement raises issues of equality/discrimination and if facilitated, encouraged or knowingly permitted by an employer (for the purpose of gain?) liability for adverse effects could be transmitted to the employer.
Adverse effects could include: fatigue, dependency, emotional variability, personality changes…
Further detail: